This event looked at the economic overview and macro trends affecting the US and Global Investment landscape over the next few months under the new administration.
Read MoreWeekly-Round-Up-March 27th to April 2nd
April 3rd, 2023 ArriVent Biopharma secures $155M in Series B Round ArriVent Biopharma, a company committed to expediting the worldwide research and development of innovative biopharmaceutical therapeutics, has completed a $155 million Series B financing. The funds will be utilized for the pivotal Phase 3 and additional studies with the Company's main product candidate furmonertinib--a highly brain penetrant, mutant-specific EGFR kinase inhibitor--as well as the company's pipeline expansion. Sofinnova Investments and General Catalyst led the f...
Read MoreWeekly-Round-Up-March 20th to March 26th
March 27th, 2023 Reebelo secures $50M in Series A Round Reebelo, a marketplace for affordable and sustainable consumer electronics, has announced a $29 million fundraising round, which brings the total series A amount to $50 million. Cathay Innovation (Global) led the financing round, with contributions from Moore Strategic Ventures (USA), Gandel Invest (Australia), and Antler (Global). This fundraising round also marks Reebelo's official launch in the United States. Numbers Station nabs $17.5M Numbers Station, an intelli...
Read MoreWeekly-Round-Up-March 13th to March 19th
March 20th, 2023 Evergreen Theragnostics secures $15M in Series B Evergreen Theragnostics, a clinical-stage contract development and manufacturing organization (CDMO) researching radiopharmaceuticals for cancer therapy, has completed a $15 million Series B capital raising. Existing shareholders utilizing their first-refusal options accounted for the majority of the subscriptions. Mitiga raises $45M Funding Series A Round Mitiga, the leader in cloud and SaaS incident response, has completed its Series A Round, taking t...
Read More
